(NYSE: PRGO) Perrigo Co's forecast annual revenue growth rate of 1.8% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.63%.
Perrigo Co's revenue in 2025 is $4,326,000,000.On average, 3 Wall Street analysts forecast PRGO's revenue for 2025 to be $606,865,410,101, with the lowest PRGO revenue forecast at $600,364,622,139, and the highest PRGO revenue forecast at $612,381,105,114. On average, 3 Wall Street analysts forecast PRGO's revenue for 2026 to be $614,459,981,434, with the lowest PRGO revenue forecast at $602,420,109,380, and the highest PRGO revenue forecast at $620,598,926,594.
In 2027, PRGO is forecast to generate $629,042,383,889 in revenue, with the lowest revenue forecast at $619,406,083,597 and the highest revenue forecast at $637,179,031,509.